CN Patent

CN108697698A — 用于治疗恶性肿瘤的组合疗法

Assigned to Xinji · Expires 2018-10-23 · 8y expired

What this patent protects

本发明提供了使用突变体IDH1酶的抑制剂和DNA脱甲基化剂的组合治疗携带IDH1突变的患者中的癌症的方法和组合物。

USPTO Abstract

本发明提供了使用突变体IDH1酶的抑制剂和DNA脱甲基化剂的组合治疗携带IDH1突变的患者中的癌症的方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN108697698A
Jurisdiction
CN
Classification
—
Expires
2018-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Xinji
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.